Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Loss of heterozygosity exposes germline mutations in complex I and drives Warburg metabolism in oncocytic carcinoma of the thyroid.

Science advances·2026

Same author

Basaloid adenosquamous carcinoma mimicking adenoid cystic carcinoma (BAC MAC): A novel subtype of head and neck squamous cell carcinoma.

Annals of diagnostic pathology·2026

Same author

Expanding HPV-Related Multiphenotypic Sinonasal Carcinoma Morphologic and Genotyping Profile: A Clinicopathological Study of 52 Latin American Cases.

The American journal of surgical pathology·2026

Same author

Frequent S100 and PAX8 expression in otitis media: Unexpected findings and potential sources of diagnostic confusion in middle ear pathology.

Annals of diagnostic pathology·2026

Same author

Pitfalls in diagnosis of metatypical adenoid cystic carcinoma.

Histopathology·2026

Same author

Diagnostic Utility of T-PIT, PIT-1, and SF-1 in Differentiating Pituitary Neuroendocrine Tumors From Sinonasal and Skull Base Tumors.

Applied immunohistochemistry & molecular morphology : AIMM·2026

Same journal

Molecular Pathology in Contemporary Surgical Practice.

Surgical pathology clinics·2026

Same journal

Beyond Blood: Liquid biopsy assays for nonplasma body fluids.

Surgical pathology clinics·2026

Same journal

The Molecular Landscape of Ovarian Neoplasms: A Review.

Surgical pathology clinics·2026

Same journal

Clinically Relevant Molecular Pathology of Endometrial Cancer.

Surgical pathology clinics·2026

Same journal

Molecular Pathology of Genitourinary Tumors: Diagnostic, Prognostic, and Therapeutic Implications.

Surgical pathology clinics·2026

Same journal

Oncogenicity and Therapeutic Implications of Molecular Biomarkers in Colorectal Carcinoma.

Surgical pathology clinics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 26, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Soft Tissue Pseudosarcomas.

Justin A Bishop¹

¹Department of Pathology, The Johns Hopkins Hospital, 401 North Broadway, Weinberg 2242, Baltimore, MD 21231, USA.

Surgical Pathology Clinics

|February 4, 2016

Summary

This summary is machine-generated.

Soft tissue pathology presents diagnostic challenges due to rare tumors and diverse lesions. This review clarifies "pseudosarcomas," focusing on non-mesenchymal, benign mesenchymal, and reactive lesions that mimic sarcomas.

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Related Experiment Videos

Last Updated: Mar 26, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Area of Science:

Pathology
Oncology
Histopathology

Background:

Soft tissue lesions pose diagnostic challenges due to rarity and morphologic diversity.
Many benign or reactive lesions can mimic malignant mesenchymal neoplasms, termed "pseudosarcomas."
Pathologists often lack sufficient exposure to rare soft tissue tumors.

Purpose of the Study:

To review malignant, non-mesenchymal neoplasms.
To discuss benign mesenchymal neoplasms that histologically mimic sarcomas.
To cover benign reactive soft tissue lesions with concerning features.

Main Methods:

Literature review of soft tissue pathology.
Analysis of diagnostic criteria for pseudosarcomas.
Categorization of lesions based on origin and behavior.

Main Results:

Identified categories include malignant non-mesenchymal tumors, benign mimics, and reactive lesions.
Highlighted features that differentiate mimics from true sarcomas.
Emphasized the importance of clinical and morphologic correlation.

Conclusions:

Accurate diagnosis of soft tissue lesions requires understanding a broad spectrum of mimics.
Distinguishing pseudosarcomas from true sarcomas is critical for patient management.
This review provides a framework for diagnosing challenging soft tissue proliferations.